Published by Iain Gilbert on 9th February 2026
(Sharecast News) - Analysts at JP Morgan raised their target price on drugmaker GSK to £22.50 on Monday on improving investor perception.
URL: http://www.digitallook.com/dl/news/story/35686524/...